Philips upgrades 'big bore' CT at ASTRO

Article

Enhancements that adjust for organ motion and better localize lesions debuted today for Philips’ Brilliance CT Big Bore at the American Society for Radiation Oncology (ASTRO) in Chicago.

Enhancements that adjust for organ motion and better localize lesions debuted today for Philips’ Brilliance CT Big Bore at the American Society for Radiation Oncology (ASTRO) in Chicago. Philips Healthcare framed the upgrades as speeding up diagnosis and improving the patient treatment planning, when scans are done on the company’s 85 cm large bore CT. Upgrades to the Brilliance CT Big Bore include RapidView 4-D Reconstruction System, which accelerates data processing; Amplitude Binning Algorithm, which adjusts for movement caused by respiration; Metal Artifact Reduction, designed to improve images resolution of sites near high density metal objects; “Sim Enhancement” Blocking Technology, which allows clinicians to mark an area for treatment and initiate treatment; and Tumor L.O.C. (Localization On Console), software that localizes and marks tumors in a simulation run at the scanner console.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.